The oxazolomycins: a structurally novel class of bioactive compounds.

Abstract

Oxazolomycin, first isolated in 1985, is a novel bioactive compound, exhibiting potent antiviral, antibacterial and cytotoxic activity, and is now known to be the parent of a wider class of compounds. The broad-spectrum activity of oxazolomycin has been attributed to its protonophoric properties. This review outlines the isolation, structural determination, biosynthesis, bioactivity, biological mode of action and synthesis of all members of this compound class. Significantly, the oxazolomycins appear to offer not only a completely novel chemotype as a bioactive lead structure, but also a chemotype, which also exhibits an unusual biological mode of action.

Statistics

020040060020132014201520162017
Citations per Year

59 Citations

Semantic Scholar estimates that this publication has 59 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Moloney2004TheOA, title={The oxazolomycins: a structurally novel class of bioactive compounds.}, author={Mark G. Moloney and Paul C Trippier and Muhammad Yaqoob and Zhao-Yang Wang}, journal={Current drug discovery technologies}, year={2004}, volume={1 3}, pages={181-99} }